Literature DB >> 3540520

Drug-induced psychiatric disorders and their management.

L E Hollister.   

Abstract

Psychiatric disorders induced by drugs are of most concern when they occur in the context of therapeutic use of a drug. Such iatrogenic psychiatric disturbances may interfere considerably with the treatment of the primary illness and may cause concern to patients, their relatives and the medical staff. Because many drugs are often used simultaneously in seriously ill patients, it may be difficult to be sure which drug may have been responsible. The best procedure is to remove those drugs which are most probable causes of the psychiatric disturbances as well as any drugs that are not truly essential for the treatment of the patient. Problems involved in evaluating the relationship between use of drugs and psychiatric disorders are considerable. Many reports are isolated cases and the denominators which might provide some idea of the potential risk are unknown. Many relationships are still controversial, such as the association of depression with sedatives, antihypertensives and oral contraceptives. Areas of uncertainty are great. Psychomotor impairment may be caused by a drug that can alter consciousness, or any drugs that can produce more delineated psychiatric syndromes. Sedative drugs are those most commonly associated with psychomotor impairment, and may include psychotherapeutic drugs, sedative antihistamines, narcotic analgesics and, of course, the widely used social drug, alcohol. Delirious states are most often associated with drugs that possess central anticholinergic actions. These include not only drugs clearly identified as anticholinergics, but also tricyclic antidepressants and anti-Parkinson drugs. Cimetidine, which is often used parenterally in seriously ill patients, is also a prominent cause. Delirium is most often seen in elderly patients and in those who have received rather large doses of drugs. The association of schizophrenic-like psychoses with dopaminomimetic drugs tends to support the prevailing dopamine hypothesis of schizophrenia. Levodopa, the dopamine precursor, and bromocriptine, a direct dopamine agonist, are examples of such relationships. Abuse of social drugs has also been thought to provide a useful model of schizophrenia. Hallucinogens are probably a rather poor model, abuse of amphetamines may provide a better model, and possibly the best is the psychotic state elicited by phencyclidine. Manic reactions are clinically difficult to differentiate from schizophrenic-like psychoses and are often produced by similar drugs. Corticosteroids may produce either manic or schizophrenic-like disorders, as well as occasionally confusion and depression.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3540520     DOI: 10.1007/BF03259854

Source DB:  PubMed          Journal:  Med Toxicol        ISSN: 0112-5966


  151 in total

1.  Rapid-onset steroid psychosis with very low dosage of prednisolone.

Authors:  J A Greeves
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

2.  Psychoses following trazodone administration.

Authors:  T B Kraft
Journal:  Am J Psychiatry       Date:  1983-10       Impact factor: 18.112

3.  Drug-associated psychiatric disturbances in medical inpatients.

Authors:  D A Danielson; J B Porter; D H Lawson; C Soubrié; H Jick
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Steroid psychoses: case report and brief overview.

Authors:  M Kaufmann; K Kahaner; E D Peselow; S Gershon
Journal:  J Clin Psychiatry       Date:  1982-02       Impact factor: 4.384

5.  Delirium associated with sulindac.

Authors:  T L Thornton
Journal:  JAMA       Date:  1980-04-25       Impact factor: 56.272

6.  A case report of cimetidine-induce depressive syndrome.

Authors:  M K Crowder; J K Pate
Journal:  Am J Psychiatry       Date:  1980-11       Impact factor: 18.112

7.  Hypomania and mania after withdrawal of tricyclic antidepressants.

Authors:  S M Mirin; A F Schatzberg; D E Creasey
Journal:  Am J Psychiatry       Date:  1981-01       Impact factor: 18.112

8.  Substitution of atenolol for propranolol in a case of propranolol-related depression.

Authors:  G N McNeil; P K Shaw; D S Dock
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Mania induced by metoclopramide: case report.

Authors:  K S Ritchie; S H Preskorn
Journal:  J Clin Psychiatry       Date:  1984-04       Impact factor: 4.384

10.  Antimalarial psychosis revisited.

Authors:  R L Evans; S Khalid; J L Kinney
Journal:  Arch Dermatol       Date:  1984-06
View more
  3 in total

Review 1.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 2.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

Review 3.  Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.

Authors:  Beena Elizabeth Thomas; Poonguzhali Shanmugam; Muniyandi Malaisamy; Senthanro Ovung; Chandra Suresh; Ramnath Subbaraman; Srividya Adinarayanan; Karikalan Nagarajan
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.